Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Uncovering the mode of action of engineered T cells in patient cancer organoids
Johanna F. Dekkers, María Alieva, Astrid Cleven, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 1, pp. 60-69
Open Access | Times Cited: 121

Showing 1-25 of 121 citing articles:

Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine
Sanae El Harane, Bochra Zidi, Nadia El Harane, et al.
Cells (2023) Vol. 12, Iss. 7, pp. 1001-1001
Open Access | Times Cited: 66
Patient-derived organoids in translational oncology and drug screening
Ruixin Yang, Yingyan Yu
Cancer Letters (2023) Vol. 562, pp. 216180-216180
Open Access | Times Cited: 58
Tumor heterogeneity: preclinical models, emerging technologies, and future applications
Marco Proietto, Martina Crippa, C. Damiani, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 56
CRISPR screens decode cancer cell pathways that trigger γδ T cell detection
Murad R. Mamedov, Shane Vedova, Jacob W. Freimer, et al.
Nature (2023) Vol. 621, Iss. 7977, pp. 188-195
Open Access | Times Cited: 48
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
Roel Polak, Elisa Zhang, Calvin J. Kuo
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 523-539
Closed Access | Times Cited: 48
Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer
Esther Strating, Mathijs Verhagen, Emerens Wensink, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 44
Neutrophils in Physiology and Pathology
Alejandra Aroca-Crevillén, Tommaso Vicanolo, Samuel Ovadia, et al.
Annual Review of Pathology Mechanisms of Disease (2024) Vol. 19, Iss. 1, pp. 227-259
Open Access | Times Cited: 39
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma
Marc Wehrli, Samantha Guinn, Filippo Birocchi, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 9, pp. 1859-1877
Closed Access | Times Cited: 29
Bridging live-cell imaging and next-generation cancer treatment
María Alieva, Amber K. L. Wezenaar, Ellen J. Wehrens, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 731-745
Closed Access | Times Cited: 38
Flourishing tumor organoids: History, emerging technology, and application
Qian Yang, Mengmeng Li, Xinming Yang, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 5
Open Access | Times Cited: 28
Harnessing 3D in vitro systems to model immune responses to solid tumours: a step towards improving and creating personalized immunotherapies
Zhenzhen Zhou, Yuan Pang, Jingyuan Ji, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 1, pp. 18-32
Closed Access | Times Cited: 28
The role of organoids in cancer research
Zhen Fang, Peijuan Li, Fengying Du, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 25
Analysis of off-tumour toxicities of T-cell-engaging bispecific antibodies via donor-matched intestinal organoids and tumouroids
Marius F. Harter, Timothy Recaldin, Régine Gérard, et al.
Nature Biomedical Engineering (2023) Vol. 8, Iss. 4, pp. 345-360
Open Access | Times Cited: 25
Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells
Tengku Ibrahim Maulana, Claudia Teufel, Madalena Cipriano, et al.
Cell stem cell (2024) Vol. 31, Iss. 7, pp. 989-1002.e9
Open Access | Times Cited: 15
Causal relationship between immune cells and hepatocellular carcinoma: a Mendelian randomisation study
Jingyi Tang, Shengke Zhang, Lai Jiang, et al.
Journal of Cancer (2024) Vol. 15, Iss. 13, pp. 4219-4231
Open Access | Times Cited: 12
Engineering innate immune cells for cancer immunotherapy
Mubin Tarannum, Xizhong Ding, Marta Barisa, et al.
Nature Biotechnology (2025) Vol. 43, Iss. 4, pp. 516-533
Closed Access | Times Cited: 1
3D Tumor Spheroid and Organoid to Model Tumor Microenvironment for Cancer Immunotherapy
Yichen Zhu, Elliot Kang, Matthew Wilson, et al.
Organoids (2022) Vol. 1, Iss. 2, pp. 149-167
Open Access | Times Cited: 34
Engineering chimeric antigen receptor T cells for solid tumour therapy
Longwei Liu, Yunjia Qu, Leonardo Cheng, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 12
Open Access | Times Cited: 29
Exploring Tumor–Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients
S.Y. Jeong, Minyong Kang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14609-14609
Open Access | Times Cited: 22
Toward reproducible tumor organoid culture: focusing on primary liver cancer
Lianming Guo, Chao Li, Weiqiang Gong
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Closing in on cancer heterogeneity with organoids
Vivien Marx
Nature Methods (2024) Vol. 21, Iss. 4, pp. 551-554
Open Access | Times Cited: 7
Perspective on quantitative phase imaging to improve precision cancer medicine
Yang Liu, Shikhar Uttam
Journal of Biomedical Optics (2024) Vol. 29, Iss. S2
Open Access | Times Cited: 7
Cancer-on-a-chip model shows that the adenomatous polyposis coli mutation impairs T cell engagement and killing of cancer spheroids
Valentin Bonnet, Erik Maikranz, Marianne Madec, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 11
Open Access | Times Cited: 6
BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor response
María Alieva, Mario Barrera Román, Sam de Blank, et al.
Nature Protocols (2024) Vol. 19, Iss. 7, pp. 2052-2084
Closed Access | Times Cited: 6
The Fate(s) of CAR T-Cell Therapy: Navigating the Risks of CAR+ T-Cell Malignancy
Mohamed Abou‐El‐Enein
Blood Cancer Discovery (2024) Vol. 5, Iss. 4, pp. 249-257
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top